~ of ill vitro release testing as a QA tool to ensure batch-to-batch uniformity has been gaini ng both increasing popularity and contempt in the pharmaceutical industry. Regardless of views and opinions, it is worthwhile to be prepared to conduct such studies if necessary. Currently, the most publicized methods use horizontal ("Franz or Modified Franz") diffusion cells, with an artificial support membrane to conduct in vitro release studies on a semisolid formu lations, typicall y creams. However, depending upon the type of formulation to be tested, and possible needs for automation, it may be desirable to investigate alternate .apparatuses and techniques. The following article gives examples of several techniques and apparatuses which could be employed in release testing of semisolid drug products. which do not impede the free diffusion of drug from the formulation. Using a membrane which is not resistant to the free diffusion of drug allows for the determination of release of drug from the semisolid formulation itself. Ln addition, it is very important to choose receptor media which maintain adequate sink conditions. Poor sink conditions andlor mixi ng will result in a large hydrodynamic boundary layer, which will both decrease the amount of drug released. and significantly lower the test's ability to determine differences between formu lations . The "goa'" in the development of such methods is to have a test which measures the "intrinsic" release of drug fTOm the formulation. In such a system. alterations in the formu lations could be measured.
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Method Development Formulations Considerations
The actual development of ill vitro release methods has been discussed in the past, and will not be addressed in detail here l . However, it is important to reiterate the need to use artificial support membranes A primary concern in the selection of an in vitro release technique is the nature of the formulation to be tested. The type of formulations which are typicall y tested fall into the broad classifications of: creams, Creams and gels have been tested using 
Common Techniques

As indicated earlier. the most popular technique for conducting in vitro
release studies is the use of horizontal "Franz" diffusion cell technology. In such studies, (see Figure I) which is maintained at 32' C. An artificial support membrane is placed over the diffusion cell opening. The formulation is applied to the membrane (typically an "infinite" amount of formulation is applied), and the cell is capped (the surface of the formulation is usually left open to room air, not occluded). The cells are stirred with a magnetic stir bar, usually at a speed of 600 rpm. Samples are then withdrawn from the measuring dissolution rather than release. However, for formulations which do not dissolve/d isperse in the receptor, thi s technique could be used to conduct in vitro release studies, usi ng well-established, universal equipment. In addition. such a technique is amenable to full automation using robotics.
Van Kel recently introduced the Enhancer Cell, which could be used for in vilro release testing. The Enhancer Cell technique is very similar to the paddle-over-disk While this technique has been proven to be quite use ful , it tends [0 be a rather complicated process, which requjres extensive training to generate reproducible resuHs. In addition, the method does not lend itself easily to full automation (i.e. having samples 
Techniques
ĩ ~~;
Another technique which has been used is the USP paddle-over disk method. [n such studies, the formulation is fill ed into a USP stainless steel disk, placed on the bouom of a dissolution vessel which is filled associated with di ssolutio n/dispersion of the formulation. As with paddle-over-disk, this technique lends itself to full automation. Another technique which can be used is the inverted rotating cylinder (Figure 3 ). This technique simply uses a machined. round cavity in a piece of Teflon or stainless steel as the "holder" of the drug produc!. Once loaded with formulation, the cylinder can be lowered into a standard USP di ssolution vessel, and rotated (typically at 50 rpm). This method does not use a membrane, and can only be used with formulation which do not dissolve or disperse in the receptor medium.
This method has been shown to be quite useful for hydrophobic ointment bases containing solubilized drug. Once again. this technique can be fully automated.
Comparison Of Techniques For Cream And Ointment Formulations
Examples of the use of the above techniques will be presented for a cream formulation (Terazol 3 Vaginal Cream, 0.8% terconazole, drug is in suspension) and an ointment (petrolatum based containing a soluble highly lipophilic drug). These two formulation s represent the extremes in formulation s. where the release of terconazole is quite rapid into an aqueous buffer. and the release of the active from the ointment is extremely slow into a hydro-alcoholic medium. Both formulations were tested using the above techniques to demonstrate the utility of each method for the formulations . All data is normalized for surface area. [n all studies, samples were taken at I, 2, 4 and 6 hours.
In Vitro Release Of Terconazole:
For all studies conducted with te[Conazole, a receptor medium of pH 4 citrate-phosphate buffer was used.
Franz Cell: Modified Franz Diffusion Cells (Crown Glass, Somerville, New Jersey), with a groundglass surface, 9 mm opening and 10 mL volume were used. An artificial membrane of a 70 lim Teflon Mesh was used.
Paddle-over-Disk: Standard USP disks were filled with I g of formulation and placed in the bottom of a USP dissolution vessel containing 250 mL of receptor media. Paddles were rotated at 50 rpm, 25 mm above the surface of the disks.
Enhancer For all studies, a receptor medium of 50% ethanol in water was used.
Franz cells and Enhancer Cells, as above, were used with 70 (lm Teflon mesh as the support membrane. Paddle-over disk studies were conducted as above. The inverted rotating cylinder was used for this formulation. since actual dissolution/dispersion of the ointment did not occur in this media.
Results
Terconazole:
Results for the ill vitro release of terconazole using the various techniques are summarized in Figure   4 . Data is presented as cumulative amount released vs the square root of time. Since the terconazole is dispersed throughout the formu lation as a solid suspension, the release profile follows the Higuchi Equation" '.
Resuhs indicated that the release of terconazole was simi lar from the Franz Cell and the Enhancer Cell. Resuhs from the inverted En hancer Cell were somewhat lower. and more variable. These lower results were most likely due to poor mixing at the surface of the membrane (the apparatus was not designed for this purpose. and mixing at the membrane surface when inverted is poor). Resuhs From the paddle-over-disk were significantly higher than those from the Franz and Enhancer Cells. This increase in release was due Careful selection of the receptor solution is of primary importance, however, even the most appropriate receptors can not over-come poor mixing conditions at the formulation/media interface. Results indicated that release was highest from the inverted rotating cylinder.
followed by the paddle-over-disk, Enhancer Cell and finally the Franz Cell. Since there was not apparent dispersion of the formulation into the media, differences in the release rates are most likely due to the effect of mixing at the formu lation/media interface.
For instance. mixing is most efficient in the inverted rotating cylinder. resulting in a lower hydrodynamic boundary layer, thereby increasing the apparent release rate. Other studies conducted at higher stirring rates suggested that the inverted rotating cylinder apparatus was approaching the intrinsic release rate.
Conclusions
In general, the Franz Diffusion Cell is the current "apparatus of choice" from a regulatory perspective"'. In the development of methods. the Franz Cell is usually the first apparatus to be inve tiga ted. However. when the fomlUlation (i.e. lipophilic ointments) or the necessity for full automation precludes the use of the Franz Cell, it may be (cofllillued on page 6) (continued from page 5) necessary to inves tigate oth er techn iques and apparatuses, such as those mentioned in this artic le. to conduct routine testi ng. Figure 4 In Vitro Release 
